Sort   by:  
 Page size 
UnknownAbnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain.
Not available
S-EPMC7959465 | biostudies-literature
UnknownLiver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19.
Not available
S-EPMC8047402 | biostudies-literature
UnknownAberrant cell cycle progression and endoreplication in regenerating livers of mice that lack a single E-type cyclin.
Not available
S-EPMC2730664 | biostudies-literature
UnknownFecal microbiota transplantation from female donors restores gut permeability and reduces liver injury and inflammation in middle-aged male mice exposed to alcohol.
Not available
S-EPMC11063254 | biostudies-literature
UnknownCyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.
Not available
S-EPMC6140539 | biostudies-literature
UnknownHepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming.
Not available
S-EPMC10540088 | biostudies-literature
UnknownFat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD).
Not available
S-EPMC8533605 | biostudies-literature
UnknownGenetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy.
Not available
S-EPMC8831621 | biostudies-literature
UnknownAn Experimental DUAL Model of Advanced Liver Damage.
Not available
S-EPMC8183170 | biostudies-literature
UnknownAnti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1.
Not available
S-EPMC10772393 | biostudies-literature
Sort   by:  
 Page size